ARTICLE | Clinical News
Zometa zoledronic acid regulatory update
January 2, 2001 8:00 AM UTC
The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of NVS's Zometa intravenous bisphosphonate to treat tumor-induced hypercalcemia. NVS has received an approvable lett...